Preliminary Program

DAY 1: Tuesday 27 November 2018 

13:00-14:00 Welcome and Registration, poster setup/poster viewing open 

14:00-14:15 Official opening and introduction by Pernette Verschure, NL 

Session 1: Epigenetic regulatory mechanisms: 'State-of-the-art epigenetics' 

14:15-15:00 Geneviève Almouzni, FR - Structure and function of dynamic chromatin organization (The EMBO Keynote Lecture)

15:00-15:30 Luciano di Croce, ES - The role of protein complexes in epigenetic reprogramming and cancer development (Invited speaker 1) 

15:30-15:45 Short talk (selected from abstracts, early stage researcher) 

15:45-16:15 Henk Stunnenberg, NL Title TBA (Invited speaker 2)

16:15-16:45 Break

16:45-17:15 Wouter de Laat, NL - The 3D Genome Promise: wiring non-coding genetic variation to genes.(Invited speaker 3) 

17:15-17:30 Short talk (selected from abstracts, early stage researcher) 

17:30-17:45 Short talk (selected from abstracts, early stage researcher) 

17:45-18:00 Short talk (selected from abstracts) 

18:00-18:30 Vahid Shahrezaei, GB - Analytical and computational methods to interpret temporal, spatial and stochastic dynamics of stochastic gene expression (Invited speaker 4)

18:30-20:00 Welcome drinks and Finger food

19:00-19:30 Meet the speakers 

20:00-20:30 Theatre performance: Epigenetic Human Simulation, produced by Orion Maxted 

20:30-21:30 Gender & Diversity get together

Panel/ open discussion

The informal ‘Gender & Diversity get together’ is open to all participants. The meeting is designed to help address challenges that minorities face in science and to support these minorities in our science communities providing an open forum for discussion and mentoring.

DAY 2: Wednesday 28 November 

Session 2: Epigenetics and clinical cancer: A systems medicine view 

09:00-09:45 Pamela Munster, US - Title TBA (Keynote Speaker) 

09:45-10:15 Lucia Altucci, IT - Innovative therapeutic strategies against cancer, (epi)drug discovery and development (Invited speaker 5) 

10:15-10:30 Short talk (selected from abstracts, early stage researcher)

10:30-11:00 Break

11:00-11:30 Christoph Plass, DE – The interaction between epigenetic and immune therapy: Induction of cryptic transcription start sites encoded by long terminal repeats (Invited speaker 6) 

11:30-11:45 Short talk (selected from abstracts, early stage researcher) 

11:45-12:15 Lodewijk Wesssels, NL - The molecular landscape of tumours: Computational approaches and predictions to treat cancer patients (Invited speaker 7) 

12:15-12:30 Short talk (selected from abstracts, early stage researcher) 

12:30-13:00 Maria Carmo-Fonseca, PT - RNA-mediated transcriptional control in stemness, oncogenesis and aging: Tailored disease treatments.(Invited speaker 8) 

13:00-13:15 Poster flashes

13:15-14:15 Lunch

13.15 - 14.15 Lunch meeting open to all conference visitors: Workshop by Illumina

Illumina Workshop: “DNA Methylation Profiling, a key player in Cancer Research”

Join us at this workshop to hear from two leading scientists using DNA Methylation profiling and learn how you, too, could benefit from its potential value in your Cancer Research.

The session will feature two presentations:

“Assessment of Global Promoter Methylation Status for Classifying Brain - and other Tumors”  

Prof. Dr. med. Andreas von Deimling. Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany

“Using DNA Methylation Profiling in Human Health and Disease”

Dr. Manel Esteller. Cancer Epigenetics and Biology Program (PEBC), Institut d'Investigació

Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain

14:15-15:45 Posters even numbers 

Session 3: Epigenetics and clinical cancer: metabolic reprogramming 

15:45-16:00 Kathrine Thedieck, D -

16:00-16:30 Massimo Loda, US (Invited speaker 9) 

16:30-16:45 Short talk (selected from abstracts, early stage researcher)

16:45-17:00 Short talk (selected from abstracts, early stage researcher) 

17:00-17:30 Titziana Bonaldi, IT - Proteomics and functional genomics to understand epigenetic gene regulation: Tools to elucidate the histone code (Invited speaker 10)

17:30-18:30 Drinks 

18:00-18:30 Meet the speakers

19:00- ... Transfer to dinner location 

19:45- ... Congress dinner 

DAY 3: Thursday 29 November 

Session 4: Innovative epigenetic interference tools and synthetic biology

09:00-09:45 Martin Fussenegger, CH - Designing treatment strategies of the future (Keynote speaker) 

09:45-10:15 Pilar Blancafort, AU - Epigenetic editing as innovative strategy of tumour targeting in pre-clinical studies (Invited speaker 11)

10:15-10:35 Talk (selected from abstracts)

10:35-11:05 Break

11:05-11:35 Toni Cathomen, DE Therapeutic genome editing – opportunities and pitfalls (Invited speaker 16)

11:35-11:50 Short talk (selected from abstracts, early stage researcher) 

11:50-12:05 Short talk (selected from abstract, early stage researcher) 

12:05-12:20 Short talk (selected from abstract, early stage researcher)

12:20-12:50 Stefan Legewie - Dynamics of estrogen-dependent transcription at the single-cell level (Invited speaker 13) 

12:50-13:15 Poster flashes

13:15-14:15 Lunch

14:15-15:45 Posters odd numbers 

15:45-16:15 Meet the speakers

16:15-18:00 Drinks and bites 

16.30-18:00 Science cafe ‘From experiment to the market’

Conducted by Pieter van Boheemen, Rathenau Institute, NL 

Invited speakers: Maria Rodriguez Martinez (IBM Research, CH), Lucia Altucci (Epi-C, Second University of Napels, IT)

The Science cafe 'From experiment to the market' will cover prospects and challenges for translation and commercialization of breakthroughs from systems epigenetics, for promising patient treatment strategies, for example (epi)genome editing technologies. 

We will also introduce ethical, societal and legal aspects and hurdles of precision medicine. The Science café will include a dialogue involving industry, the research community as well as scholars with relevant social science and science policy making expertise raising, awareness of this exciting field. 

DAY 4: Friday 30 November 

Session 5: Epigenetics, cell heterogeneity and cancer stem cells driving tumour evolution

09:00-09:15 Poster prize awarding 

09:15-10:00 Jonathan Chubb, GB - Implications of transcriptional mechanism for cell decision-making (Keynote speaker)

10:00-10:30 Luca Magnani, GB - Epigenomic maps in breast cancer to understand regulatory networks of cancer cells and determine therapy responsiveness (Invited speaker 14)

10:30-10:50 Talk (selected from abstracts)

10:50-11:20 Break

11:20-11:50 Maria Rodriguez Martinez, CH - Unravelling tumour heterogeneity with single cell proteomics (Invited speaker 15)

11:50-12:05 Short talk (selected from abstracts, early stage researcher) 

12:05-12:35 Anne-Lise Børresen-Dale, NO (Invited speaker 17)

12:35-13:05 Paola Scaffidi, GB - Intra-tumour heterogeneity and the role of cancer stem cells (Invited speaker 16)

13:05-13:15 Meeting closure


EpiPredict Conference 2018 - Amsterdam, The Netherlands
    • Location

      KIT - Royal Tropical Institute
      Mauritskade 63
      1092 AD Amsterdam
      The Netherlands

      Follow us

    • Keep me updated